Brief: TScan Therapeutics Reports Third Quarter 2023 Financial Results And Provides Corporate Update

Tscan Therapeutics

09/11/2023 12:30

Nov 9 (Reuters) - Tscan Therapeutics Inc  TCRX.O :
    * TSCAN THERAPEUTICS REPORTS THIRD QUARTER 2023 FINANCIAL
RESULTS
AND PROVIDES CORPORATE UPDATE
    * SAYS ENDED Q3 WITH CASH, CASH EQUIVALENTS, AND MARKETABLE
SECURITIES OF $215.4 MILLION, FUNDING OPERATIONS INTO 2026
    * SAYS REVENUE FOR Q3 ENDED SEPTEMBER 30, 2023, WAS $3.9
MILLION,
COMPARED TO $3.4 MILLION FOR Q3 ENDED SEPTEMBER 30, 2022
    * QTRLY NET LOSS PER SHARE, BASIC AND DILUTED $0.24
    * Q3 EARNINGS PER SHARE VIEW $-0.45, REVENUE VIEW $4.1
MILLION --
LSEG IBES DATA

Source text for Eikon:  ID:nGNX4plmjn 
Further company coverage:  TCRX.O 

 ((Reuters.Briefs@thomsonreuters.com;))